MARIO
FERNÁNDEZ RUIZ
Profesor asociado de Ciencias de la Salud
Instituto de Salud Carlos III
Madrid, EspañaInstituto de Salud Carlos III -ko ikertzaileekin lankidetzan egindako argitalpenak (30)
2024
-
Cytomegalovirus UL44 protein induces a potent T-cell immune response in mice
Antiviral Research, Vol. 227
-
Natural history and prognostic factors of candidemia in kidney transplant recipients: A retrospective, multinational study
Mycoses, Vol. 67, Núm. 1
2022
-
Derivation of a score to predict infection due to multidrug-resistant Pseudomonas aeruginosa: a tool for guiding empirical antibiotic treatment
Journal of Global Antimicrobial Resistance, Vol. 29, pp. 215-221
-
Immunoguided Discontinuation of Prophylaxis for Cytomegalovirus Disease in Kidney Transplant Recipients Treated With Antithymocyte Globulin: A Randomized Clinical Trial
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 74, Núm. 5, pp. 757-765
-
Progressive Multifocal Leukoencephalopathy
Infectious Complications in Biologic and Targeted Therapies (Springer International Publishing), pp. 417-430
-
Role of cytomegalovirus infection after kidney transplantation on the subsequent risk of atherosclerotic and thrombotic events
Atherosclerosis Plus, Vol. 48, pp. 37-46
2021
-
COVID-19 in Solid Organ Transplant Recipients in Spain Throughout 2020: Catching the Wave?
Transplantation, Vol. 105, Núm. 10, pp. 2146-2155
-
Efficacy of β-lactam/β-lactamase inhibitors to treat extended-spectrum beta-lactamase-producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT-SOT Project)
Transplant infectious disease : an official journal of the Transplantation Society, Vol. 23, Núm. 3, pp. e13520
-
IL-6–based mortality prediction model for COVID-19: Validation and update in multicenter and second wave cohorts
Journal of Allergy and Clinical Immunology, Vol. 147, Núm. 5, pp. 1652-1661.e1
-
Invasive aspergillosis in solid organ transplantation: Diagnostic challenges and differences in outcome in a Spanish national cohort (Diaspersot study)
Mycoses, Vol. 64, Núm. 11, pp. 1334-1345
-
Invasive fusariosis in nonneutropenic patients, Spain, 2000-2015
Emerging Infectious Diseases, Vol. 27, Núm. 1, pp. 26-35
-
Pretransplant CMV-Specific T-Cell Immunity But Not Dose of Antithymocyte Globulin Is Associated With Recovery of Specific Immunity After Kidney Transplantation
The Journal of infectious diseases, Vol. 223, Núm. 7, pp. 1205-1213
2020
-
A critical review of the relationship between post-transplant atherosclerotic events and cytomegalovirus exposure in kidney transplant recipients
Expert Review of Anti-Infective Therapy, Vol. 18, Núm. 2, pp. 113-125
-
Direct T-cell Inhibition and Agents Targeting T-cell Migration and Chemotaxis
Infectious Disease Clinics of North America, Vol. 34, Núm. 2, pp. 191-210
-
Infectious complications of rheumatoid arthritis and psoriatic arthritis during targeted and biological therapies: A viewpoint in 2020
Annals of the Rheumatic Diseases, Vol. 79, Núm. 12, pp. 1532-1543
-
Predictive tools to determine risk of infection in kidney transplant recipients
Expert Review of Anti-Infective Therapy, Vol. 18, Núm. 5, pp. 423-441
-
Predictors of mortality in solid organ transplant recipients with bloodstream infections due to carbapenemase-producing Enterobacterales: The impact of cytomegalovirus disease and lymphopenia
American Journal of Transplantation, Vol. 20, Núm. 6, pp. 1629-1641
2019
-
Monitoring of alphatorquevirus DNA levels for the prediction of immunosuppression-related complications after kidney transplantation
American Journal of Transplantation, Vol. 19, Núm. 4, pp. 1139-1149
2018
-
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52)
Clinical Microbiology and Infection, Vol. 24, pp. S71-S82
-
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Cell surface receptors and associated signaling pathways)
Clinical Microbiology and Infection, Vol. 24, pp. S41-S52